Salarius Pharmaceuticals Inc (SLRX) is a biotechnology company listed on NASDAQ.
Latest reported SLRX revenue for 2023-03-31 was $0. Net income was -$5.3M. SLRX currently screens at market cap $4.9M.
Use this SLRX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the SLRX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the SLRX SEC filings page. Lician reads the product cache first so this HTML stays unique to Salarius Pharmaceuticals Inc even when a live quote feed is slow.
Latest cached year on this hub. Full SLRX income, balance, and cash tables.